Alnylam Pharmaceuticals
Business Account Executive - Onpattro: Southern NJ (Finance)
(This includes Trenton, Edison, and Camden, NJ, Mid-Atlantic Region)
Overview
Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality, and is now advancing a robust pipeline of investigational RNAi therapeutic medicines, including five programs in late-stage development. In 2018, Alnylam received approval for our first product, the first-ever RNAi therapeutic, by the FDA in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and by the European Medicines Agency in the EU for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. Headquartered in Cambridge, Mass., Alnylam employs over 1,200 people in 18 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work four years in a row (2015-2018) and a Great Place to Work in the U.K. and Switzerland in 2019. Please visit www.alnylam.com for more information.
We are looking for experienced Business Account Executives (BAEs) with rare disease experience to promote ONPATTRO (patisiran) in the U.S. ONPATTRO was approved in August 2018 by the FDA for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adults.
hATTR amyloidosis is a little-known condition in the United States and patients often spend years undiagnosed and misdiagnosed. There is an amazing opportunity to educate and enhance the market's knowledge of hATTR amyloidosis.
The hATTR amyloidosis BAE (ON BAE) will be principally responsible for driving physician and patient identification, disease awareness, overall market development, and brand awareness within their ascribed territory. The BAE will be responsible for achieving territory targets and other business objectives through account and customer strategies, while also partnering & collaborating very closely with internal and external stakeholders to effectively manage all aspects of the regional business. The achievement of targets will be based in Alnylam values: our commitment to people, sense of urgency, passion for excellence, innovation & discovery, open culture as well as our unwavering commitment to integrity.
The position reports into the ONPATTRO (ON) Regional Business Director.
Summary of Key Responsibilities
Qualifications
Clear Alignment with Alnylam Core Values
Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment. #LI- BS1